Groundbreaking Publication Using AI for Disease Classification in Hidradenitis suppurativa by using Scarletred®Vision
Read our groundbreaking publication establishing the first AI benchmark in automated disease classification in Hidradenitis suppurativa (HS) patients by using Scarletred®Vision und calibrated clinical images.
“A pioneer in the global healthcare industry”: SCARLETRED Featured in EU Start Up News About AI in Healthcare
EU Startup News covers innovative startups and emerging trends in the tech industry and talks about SCARLETRED providing standardization and objective skin analysis as a pioneering digital health scaleup.
7th Dermatology Drug Development Summit in Boston: Scarletred Joins as Lead & Hosting Partner and Expert Speaker
The 7th Dermatology Drug Development Summit in Boston, USA, for inflammatory skin diseases presents novel therapeutics for rare and common skin diseases such as Atopic Dermatitis, Hidradenitis suppurativa, and more.
SCARLETRED at Round-Table Discussion of Börse Express about Life Science Industry in Austria
In the round table discussion of the leading financial domain Börse Express, Marinomed, Scarletred, PHH Rechtsanwälte, and EOSS Industries discussed the development and hurdles of Austrian life science start-ups.
Epidermolysis Bullosa - How Does Remote Wound Care in Rare Skin Diseases Work?
SCARLETRED’s certified medical device provides medical professionals with a novel digital solution to allow them to assess and analyze the individuals’ affected areas in an accurate, time-efficient, and user-friendly manner.
Scarletred®Vision: A Scalable Digital Solution for Measurement of the Individual Typology Angle (ITA°) and Changes in the Skin Tone
SCARLETRED’s mobile technology, Scarletred®Vision, provides clinically validated R&D tools to document, analyse, and monitor skin color and pigmentation variations in multi-centric or home based cosmetics studies.
Rosacea Objective Standardized Analysis: Quantitative Assessment of Erythema and Skin Texture Alterations
Being a chronic inflammatory skin disorder, patients with rosacea need standardized tools, as provided by SCARLETRED, to improve the condition’s analysis and treatment and overcome psychosocial stigmatization.